Psoriatic Arthritis
The Pharmacy Times® Psoriatic Arthritis resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
![[[thumbnail_alt_text]]](https://ajpblive.s3.amazonaws.com/_media/_image/psoriasis drug rx.jpg)
Risankizumab shows promise as an important treatment option for people living with plaque psoriasis.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/v1_media/SafeImages/Webdam%20Assets/colorful%20pills.jpg)
Ron Lanton III, Esq, President, True North Political Solutions, makes predictions about how dealings with biosimilars may change in 2018.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/v1_media/SafeImages/Webdam%20Assets/FDA5-644px.jpg)
Tofacitinib (Xeljanz/Xeljanz XR) improves disease severity for patients with psoriatic arthritis.
![[[thumbnail_alt_text]]](https://specialtypharmacytimes.s3.amazonaws.com/v1_media/_thumbs/Article Images/_thumbnails/Psoriasis.jpg)
Up to 90% of patients with psoriasis develop plaque on their nails, palms of the hands, and soles of the feet.
![[[thumbnail_alt_text]]](https://specialtypharmacytimes.s3.amazonaws.com/v1_media/_thumbs/v1_media/_upload_image/_thumbnails/Atopic dermatitis - hands spt.jpg)
Hay fever and asthma are dependent on allergens that stimulate the immunoglobulin E pathway, which is not the case with atopic dermatitis.
![[[thumbnail_alt_text]]](https://specialtypharmacytimes.s3.amazonaws.com/v1_media/_thumbs/v1_media/_upload_image/_thumbnails/PsA drug efficacy.jpg)
Ixekizumab found to provide significant improvement in joint symptoms for patients not previously treated with a biologic disease-modifying antirheumatic drug.
![[[thumbnail_alt_text]]](https://ajpblive.s3.amazonaws.com/_media/_image/psoriasis hand.jpg)
Patients with moderate-to-severe nail psoriasis treated with secukinumab experienced significant improvement in the Nail Psoriasis Severity Index.
![[[thumbnail_alt_text]]](https://specialtypharmacytimes.s3.amazonaws.com/v1_media/_thumbs/Article Images/_thumbnails/PsA180x135.jpg)
Secukinumab (Cosentyx) treatment observed to improve the signs and symptoms of psoriatic arthritis.
New Drug Applications filed for halobetasol propionate and tazarotene lotion, a topical treatment for plaque psoriasis.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/vivid/pharmacytimes.jpg)
Treatment for psoriatic arthritis may impact symptoms and patient-reported outcomes.
![[[thumbnail_alt_text]]](https://specialtypharmacytimes.s3.amazonaws.com/v1_media/_thumbs/v1_media/_upload_image/_thumbnails/PsA therapy.jpg)
Patients with active psoriatic arthritis experience significant work instability based on disease activity.
![[[thumbnail_alt_text]]](https://specialtypharmacytimes.s3.amazonaws.com/v1_media/_thumbs/v1_media/_upload_image/_thumbnails/PsA drug trial.jpg)
Several modalities found to be effective in the triage of psoriasis patients with musculoskeletal symptoms, according to a study presented at the 2017 American College of Rheumatology meeting.